LOG P IN RELATION TO SOME GEOMETRICAL PROPERTIES OF APOLAR MOLECULESBULTSMA T.1980; EUROP. J. MEDICIN. CHEM.; FRA; DA. 1980; VOL. 15; NO 4; PP. 371-374; ABS. FRE/GER; BIBL. 19 REF.Article

APPLICATION OF LOCAL COMPOSITION THEORY TO ERYTHROCYTE MEMBRANE-BUFFER PARTITIONING OF N-ALKYLPHENYLKETONESGRUENBAUER HJM; BULTSMA T; REKKER RF et al.1982; EUR. J. MED. CHEM.; ISSN 0223-5234; FRA; DA. 1982; VOL. 17; NO 5; PP. 421-428; ABS. FRE/GER; BIBL. 27 REF.Article

PHARMACOCHEMISTRY OF 2-DIARYLMETHYL-1,3-INDANDIONES. III. CONFORMATIONAL CALCULATIONS.DE WINTER ML; BULTSMA T; NAUTA WT et al.1977; EUROP. J. MEDICIN. CHEM.; FR.; DA. 1977; VOL. 12; NO 2; PP. 137-141; ABS. FR. ALLEM.; BIBL. 19 REF.Article

PARTITION COEFFICIENTS FROM A LOCAL COMPOSITION THEORYGRUENBAUER HJM; BULTSMA T; REKKER RR et al.1982; EUR. J. MED. CHEM.; ISSN 0223-5234; FRA; DA. 1982; VOL. 17; NO 5; PP. 411-420; ABS. FRE/GER; BIBL. 37 REF.Article

INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS BY 2-ARYL-1,3-INDANDIONES. = INHIBITION DE LA BIOSYNTHESE DES PROSTAGLANDINES PAR LES ARYL-2 INDANEDIONES-1,3VANDENBERG G; BULTSMA T; NAUTA WT et al.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 10; PP. 1115-1119; BIBL. 33 REF.Article

INTEGRATED QSAR OF H₁-RECEPTOR ANTAGONISTSREKKER RF; NAUTA WT; BULTSMA T et al.1975; EUROP. J. MEDICIN. CHEM.; FR.; DA. 1975; VOL. 10; NO 6; PP. 557-562; ABS. FR. ALLEM.; BIBL. 21 REF.Article

STRUCTURE-ACTIVE RELATIONSHIPS OF 2-ARYL-1,3-INDANDIONEVAN DEN BERG G; BULTSMA T; REKKER RF et al.1975; EUROP. J. MEDICIN. CHEM.; FR.; DA. 1975; VOL. 10; NO 3; PP. 242-246; ABS. FR. ALLEM.; BIBL. 25 REF.Article

Binding characteristics of the regulatory guanine nucleotide binding protein, and the activation of the enzyme adenylate cyclase, present in a bovine skeletal muscle membrane preparationIJZERMAN, A. D; BULTSMA, T; TIMMERMAN, H et al.Research communications in chemical pathology and pharmacology. 1986, Vol 52, Num 1, pp 93-105, issn 0034-5164Article

Quantitative evaluation of the β₂-adrenoceptror intrinsic activity of N-tert-butylphenylethanolaminesIJZERMAN, A. P; BULTSMA, T; TIMMERMAN, H et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 4, pp 549-554, issn 0022-2623Article

Mapping the turkey erythrocyte β receptor: a distance geometry approachLINSCHOTEN, M. R; BULTSMA, T; IJZERMAN, A. P et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 2, pp 278-286, issn 0022-2623Article

The ionization of β-adrenoceptor agonists: a method for unravelling ionization schemesIJZERMAN, A. P; BULTSMA, T; TIMMERMAN, H et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 1, pp 11-15, issn 0022-3573Article

Influence of eluent composition on lipophilicity measurements using reversed-phase thin-layer chromatographyGRUNBAUER, H. J. M; BIJLOO, G. J; BULTSMA, T et al.Journal of chromatography. 1983, Vol 270, pp 87-96, issn 0021-9673Article

The relation between ionization and affinity of β-adrenoceptor ligandsIJZERMAN, A. P; BULTSMA, T; TIMMERMAN, H et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 327, Num 4, pp 293-298, issn 0028-1298Article

Quantitative evaluation of the β₂-adrenoceptor affinity of phenoxypropanolamines and phenylethanolaminesIJZERMAN, A. P; AUE, G. H. J; BULTSMA, T et al.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 9, pp 1328-1334, issn 0022-2623Article

Mapping of the β₂-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor statesDONNE-OP DEN KELDER, G. M; BULTSMA, T; TIMMERMAN, H et al.Journal of medicinal chemistry (Print). 1988, Vol 31, Num 6, pp 1069-1079, issn 0022-2623Article